|
Volumn 47, Issue 5, 2001, Pages 153-155
|
Genetically modified dendritic cell-based cancer vaccines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CA 125 ANTIGEN;
CANCER VACCINE;
CARCINOEMBRYONIC ANTIGEN;
CYTOKINE;
GLYCOPROTEIN GP 100;
ONCOPROTEIN;
PEPTIDE;
TUMOR ANTIGEN;
VIRUS VECTOR;
ANTIGEN PRESENTING CELL;
CANCER;
CELL LYSATE;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DENDRITIC CELL;
DNA MODIFICATION;
DRUG DELIVERY SYSTEM;
EDITORIAL;
GENE INSERTION;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
NONHUMAN;
RETROVIRUS;
T LYMPHOCYTE ACTIVATION;
|
EID: 0034774964
PISSN: 00155500
EISSN: 25337602
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (5)
|
References (16)
|